525 results

• $175M Awarded in Latest Roundup Lawsuit Brought By Gardener Diagnosed With Non-Hodgkins Lymphoma

  October 30, 2023

  Irvin Jackson

  A jury has found Bayer and Monsanto liable for $175 million in a Roundup lawsuit filed by a man who developed non-Hodgkin's lymphoma after using the weed killer in his garden for 20 years.

• Roundup non-Hodgkins Lymphoma Lawsuit Ends in $1.25M Verdict Against Bayer

  October 23, 2023

  Irvin Jackson

  A jury in Missouri wants Bayer to pay $1.25 million in compensatory damages as the result of a Roundup lawsuit by a St. Louis man who says he developed non-Hodgkin's lymphoma after using the weed killer.

• Roundup Cancer Trial Ends in Defense Verdict in Missouri Court

  May 25, 2023

  Irvin Jackson

  A Roundup cancer lawsuit has ended in a defense verdict in Missouri state court.

• Roundup Class Action Settlement Objection Will Not Be Considered by U.S. Supreme Court

  May 17, 2023

  Irvin Jackson

  The U.S. Supreme Court has refused to review a decision upholding a $39 million Roundup class action settlement agreement.

• Roundup Jury Trial Over Non-Hodgkin’s Lymphoma Risk Underway in St. Louis

  April 27, 2023

  Irvin Jackson

  A St. Louis County jury has begun hearing a trial over whether Roundup non-Hodgkin's lymphoma risks led to a woman developing cancer.

• Roundup Exposure May Increase Children’s Risk of Liver Disease and Diabetes: Study

  March 16, 2023

  Irvin Jackson

  The findings of a new study like Roundup exposure to an increased risk of diabetes, liver cancer.

• New Study Reinforces Link Between Exposure to Roundup and Cancer Risk

  January 31, 2023

  Irvin Jackson

  Federal researchers say they have linked exposure to Roundup to increased urinary oxidative stress, a known biomarker for increased cancer risks.

• Autism Test for Toxic Metals and Chemical Exposures Could Provide Early Diagnosis Before Symptoms Appear: Study

  January 13, 2023

  Martha Garcia

  A new autism test using hair samples could help predict the condition in infants as young as a month old, according to a new study.

• Horizon Therapeutics Acquired for Nearly $30B Amid Growing Threat of Tepezza Lawsuit Payouts

  December 15, 2022

  Irvin Jackson

  Despite the threat of having to eventually pay Tepezza lawsuit payouts, Amgen has acquired the drug's manufacturer, Horizon Pharmaceuticals for nearly $30 billion.

• Roundup May Increase Risk Antibiotic Resistance to Bacterial Infection That Kills Thousands of Americans Every Year: Study

  December 7, 2022

  Irvin Jackson

  The findings of a new study warn that Roundup exposure could lead to the development of antibiotic resistance in dangerous, infection-causing microorganisms.